NL-OMON34793
已完成
不适用
Selective mutism - A follow up study - Selective mutism - A follow up study
niversitair Medisch Centrum Utrecht0 个研究点目标入组 100 人待定
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- selective mutism - speech deficit
- 发起方
- niversitair Medisch Centrum Utrecht
- 入组人数
- 100
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •clinical DSM\-IV diagnosis of selective mutism
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
招募中
不适用
A propective randomized split-mouth study with modified and conventional sandblasted acid-etched implants in irradiated oral squamous cell carcinoma patientsK08.2Atrophy of edentulous alveolar ridgeDRKS00025177Medentis Medical GmbH32
已完成
不适用
Prospective, randomized clinical split-mouth study investigating the clinical performance of CAD/CAM fabricated partial ceramic crowns inserted with a combination of self-etching adhesive and luting composite (ELX759 / Suglue-10, 3M ESPE, Seefeld) (1) with and (2) without selective enamel etching in comparison to a self-adhesive luting material (RXU2, 3M ESPE, Seefeld)K02Dental cariesDRKS00003059DirektorPoliklinik für Zahnerhaltung und ParodontologieKlinikum der Universität Regensburg50
进行中（未招募）
1 期
An efficacy study of the oral drug Debio 1347 in patients with solid tumors having an alteration of FGFR 1-3 (fusion)EUCTR2018-003584-53-ATDebiopharm International SA125
进行中（未招募）
1 期
An efficacy study of the oral drug Debio 1347 in patients with solid tumors having an alteration of FGFR 1-3 (fusion)EUCTR2018-003584-53-CZDebiopharm International SA125
进行中（未招募）
1 期
An efficacy study of the oral drug Debio 1347 in patients with solid tumors having an alteration of FGFR 1-3 (fusion)EUCTR2018-003584-53-DKDebiopharm International SA125